Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase III Safety and Efficacy Study of Symbicort Turbuhaler in Japanese Patients with Asthma
jRCT2080220267Phase 3
- Sponsor
- AstraZeneca
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of budesonide in asthma (3 arms), sponsored by AstraZeneca.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080220267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220267.